AstraZeneca Hits Sandoz With Seroquel Patent Suit
AstraZeneca Pharmaceuticals LP has filed suit against the generics arm of Novartis AG in an attempt to stave off competition in the multibillion-dollar market for schizophrenia and bipolar mania treatment Seroquel....To view the full article, register now.
Already a subscriber? Click here to view full article